Percent Free PSA
作者： Kenneth G. Nepple , Gurdarshan S. Sandhu , Adam S. Kibel
DOI: 10.1007/978-1-62703-188-2_5
关键词: Prostate cancer 、 Disease 、 Free psa 、 Early detection 、 Hyperplasia 、 Urology 、 Prostate cancer risk 、 Prostate biopsy 、 Serum markers 、 Medicine
摘要: The introduction of PSA in 1987 (Stamey et al. N Engl J Med 317(15):909–16, 1987) as a serum marker for prostate cancer and its subsequent development screening test early detection (Catalona 324(17):1156–61, 1991) dramatically altered the diagnosis management this disease. correlated directly with risk and, therefore, was relatively sensitive to identify men at risk. However, it became rapidly apparent that had limited specificity. Numerous nonmalignant processes, such benign prostatic hyperplasia (BPH) infection, also resulted elevations (Nadler Urol 154(2 Pt 1):407–13, 1995).
springer.com
sci-hub.st 参考文章(42)
W. Kindermann, V. Lehmann, M. Herrmann, T. Loch, Beeinflussung der PSA-Konzentration im Serum durch körperliche Belastung (insbesondere Fahrradfahren) Urologe A. ,vol. 50, pp. 188- 196 ,(2011) , 10.1007/S00120-010-2489-Z
Erim Erdem, Necmettin Atsü, Cem Akbal, Cenk Y. Bilen, Ali Ergen, Haluk Özen, The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer International Urology and Nephrology. ,vol. 34, pp. 519- 523 ,(2002) , 10.1023/A:1025685718493
Osama M Zaytoun, Michael W Kattan, Ayman S Moussa, Jianbo Li, Changhong Yu, J Stephen Jones, None, Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information. Urology. ,vol. 78, pp. 392- 398 ,(2011) , 10.1016/J.UROLOGY.2011.04.042
Robert K. Nam, Refik Saskin, Yuna Lee, Ying Liu, Calvin Law, Laurence H. Klotz, D. Andrew Loblaw, John Trachtenberg, Aleksandra Stanimirovic, Andrew E. Simor, Arun Seth, David R. Urbach, Steven A. Narod, Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. The Journal of Urology. ,vol. 183, pp. 963- 969 ,(2010) , 10.1016/J.JURO.2012.11.015
Axel Heidenreich, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Malcolm Mason, Vsevolod Matveev, Nicolas Mottet, Hans-Peter Schmid, Theo van der Kwast, Thomas Wiegel, Filliberto Zattoni, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European Urology. ,vol. 59, pp. 61- 71 ,(2011) , 10.1016/J.EURURO.2010.10.039
Markus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, Peter G Hammerer, Alexander Haese, Jüri Palisaar, Edith Huland, Peter T Scardino, Michael W Kattan, Hartwig Huland, None, PERCENT FREE PROSTATE SPECIFIC ANTIGEN IS NOT AN INDEPENDENT PREDICTOR OF ORGAN CONFINEMENT OR PROSTATE SPECIFIC ANTIGEN RECURRENCE IN UNSCREENED PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY The Journal of Urology. ,vol. 167, pp. 1306- 1309 ,(2002) , 10.1016/S0022-5347(05)65287-1
Yoshitomo Kobori, Yasuhide Kitagawa, Atsushi Mizokami, Kazuto Komatsu, Mikio Namiki, Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion. International Journal of Clinical Oncology. ,vol. 13, pp. 229- 232 ,(2008) , 10.1007/S10147-007-0742-2
Byron H. Lee, Ayman S. Moussa, Jianbo Li, Khaled Fareed, J. Stephen Jones, Percentage of Free Prostate-specific Antigen: Implications in Modern Extended Scheme Prostate Biopsy Urology. ,vol. 77, pp. 899- 903 ,(2011) , 10.1016/J.UROLOGY.2010.06.072
Kimberly A. Roehl, Jo ANN V. Antenor, William J. Catalona, Robustness of Free Prostate Specific Antigen Measurements to Reduce Unnecessary Biopsies in the 2.6 to 4.0 ng./ml. Range The Journal of Urology. ,vol. 168, pp. 922- 925 ,(2002) , 10.1016/S0022-5347(05)64543-0
David W. Keetch, Gerald L. Andriole, Timothy L. Ratliff, William J. Catalona, Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting Urology. ,vol. 50, pp. 901- 905 ,(1998) , 10.1016/S0090-4295(97)00453-6